Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 292

    1.

    [Clinical cases, a panacea view of medicine: from the simple anecdote to teaching practice]

    Lefebvre PJ, Scheen AJ.

    Rev Med Liege. 2009 Jul-Aug;64(7-8):357. French. No abstract available. PMID: 19777909 [PubMed - indexed for MEDLINE]Related articles

    2.

    [United Kingdom Prospective Diabetes Study (UKPDS): 10 years later]

    Scheen AJ, Paquot N, Lefebvre PJ.

    Rev Med Liege. 2008 Oct;63(10):624-9. French. PMID: 19009971 [PubMed - indexed for MEDLINE]Related articles

    3.

    [Brain, a gluco-dependent organ: toxic effects of hypoglycaemia and hyperglycaemia]

    Radermecker RR, Philips JC, Jandrain BJ, Paquot N, Lefèbvre PJ, Scheen AJ.

    Rev Med Liege. 2008 May-Jun;63(5-6):280-6. French. PMID: 18669193 [PubMed - indexed for MEDLINE]Related articles

    4.

    [How to explore...the metabolic syndrome by its new IDF definition]

    Scheen AJ, Luyckx FH, Lefebvre PJ.

    Rev Med Liege. 2006 Jan;61(1):48-52. Review. French. PMID: 16491549 [PubMed - indexed for MEDLINE]Related articles

    5.

    [Proactive study: secondary cardiovascular prevention with pioglitazione in type 2 diabetic patients]

    Scheen AJ, Lefèbvre PJ.

    Rev Med Liege. 2005 Nov;60(11):896-901. French. PMID: 16402538 [PubMed - indexed for MEDLINE]Related articles

    6.

    Does insulin release kinins in rats?

    Damas J, Garbacki N, Lefèbvre PJ.

    Eur J Pharmacol. 2005 Nov 21;525(1-3):154-60. Epub 2005 Nov 16.PMID: 16297383 [PubMed - indexed for MEDLINE]Related articles

    7.

    Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial.

    Dormandy JA, Charbonnel B, Eckland DJ, Erdmann E, Massi-Benedetti M, Moules IK, Skene AM, Tan MH, Lefèbvre PJ, Murray GD, Standl E, Wilcox RG, Wilhelmsen L, Betteridge J, Birkeland K, Golay A, Heine RJ, Korányi L, Laakso M, Mokán M, Norkus A, Pirags V, Podar T, Scheen A, Scherbaum W, Schernthaner G, Schmitz O, Skrha J, Smith U, Taton J; PROactive investigators.

    Lancet. 2005 Oct 8;366(9493):1279-89.PMID: 16214598 [PubMed - indexed for MEDLINE]Related articles

    8.

    Modulation of the renal response to ACE inhibition by ACE insertion/deletion polymorphism during hyperglycemia in normotensive, normoalbuminuric type 1 diabetic patients.

    Weekers L, Bouhanick B, Hadjadj S, Gallois Y, Roussel R, Pean F, Ankotche A, Chatellier G, Alhenc-Gelas F, Lefebvre PJ, Marre M.

    Diabetes. 2005 Oct;54(10):2961-7.PMID: 16186399 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    [Diabetes mellitus: epilogue]

    Scheen AJ, Lefèbvre PJ.

    Rev Med Liege. 2005 May-Jun;60(5-6):628-31. French. No abstract available. PMID: 16035341 [PubMed - indexed for MEDLINE]Related articles

    10.

    [Another look at the implications of the DCCT study]

    Krzentowski G, Zhang L, Albert A, Lefèbvre PJ.

    Ann Endocrinol (Paris). 2004 Oct;65(5):429-35. Review. French. PMID: 15550885 [PubMed - indexed for MEDLINE]Related articles

    11.

    Different patterns of insulin resistance in relatives of type 1 diabetic patients with retinopathy or nephropathy: the Genesis France-Belgium Study.

    Hadjadj S, Péan F, Gallois Y, Passa P, Aubert R, Weekers L, Rigalleau V, Bauduceau B, Bekherraz A, Roussel R, Dussol B, Rodier M, Marechaud R, Lefebvre PJ, Marre M; Genesis France-Belgium Study.

    Diabetes Care. 2004 Nov;27(11):2661-8.PMID: 15505002 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    The kallikrein-kinin system, angiotensin converting enzyme inhibitors and insulin sensitivity.

    Damas J, Garbacki N, Lefèbvre PJ.

    Diabetes Metab Res Rev. 2004 Jul-Aug;20(4):288-97. Review.PMID: 15250031 [PubMed - indexed for MEDLINE]Related articles

    13.

    [Reactive hypoglycaemia, a mysterious, insidious but non dangerous critical phenomenon]

    Scheen AJ, Lefèbvre PJ.

    Rev Med Liege. 2004 Apr;59(4):237-42. Review. French. PMID: 15182036 [PubMed - indexed for MEDLINE]Related articles

    14.

    Intact cross-talk between insulin secretion and insulin action after postgastroplasty recovery of ideal body weight in severely obese patients.

    Letiexhe MR, Desaive C, Lefèbvre PJ, Scheen AJ.

    Int J Obes Relat Metab Disord. 2004 Jun;28(6):821-3.PMID: 15052278 [PubMed - indexed for MEDLINE]Related articles

    15.

    [Prevention of cardiovascular diseases using a combined pharmacological approach: is there any place for a "polypill"?]

    Scheen AJ, Lefèbvre PJ, Kulbertus H.

    Rev Med Liege. 2003 Sep;58(9):527-33. Review. French. PMID: 14626644 [PubMed - indexed for MEDLINE]Related articles

    16.

    Factors predictive of nephropathy in DCCT Type 1 diabetic patients with good or poor metabolic control.

    Zhang L, Krzentowski G, Albert A, Lefèbvre PJ.

    Diabet Med. 2003 Jul;20(7):580-5.PMID: 12823241 [PubMed - indexed for MEDLINE]Related articles

    17.

    The intriguing diversity of the glucagon gene products.

    Lefèbvre PJ.

    Curr Diab Rep. 2002 Jun;2(3):201-2. No abstract available. PMID: 12643173 [PubMed - indexed for MEDLINE]Related articles

    18.

    [Postprandial hyperglycemia. I. Physiopathology, clinical consequences and dietary management]

    Scheen AJ, Paquot N, Jandrain B, Lefèbvre PJ.

    Rev Med Liege. 2002 Mar;57(3):138-41. Review. French. PMID: 12014260 [PubMed - indexed for MEDLINE]Related articles

    19.

    Long-term effects of oral estradiol and dydrogesterone on carbohydrate metabolism in postmenopausal women.

    Gaspard UJ, Wery OJ, Scheen AJ, Jaminet C, Lefebvre PJ.

    Climacteric. 1999 Jun;2(2):93-100.PMID: 11910673 [PubMed - indexed for MEDLINE]Related articles

    20.

    Hepatic insulin resistance in obese non-diabetic subjects and in type 2 diabetic patients.

    Paquot N, Scheen AJ, Dirlewanger M, Lefèbvre PJ, Tappy L.

    Obes Res. 2002 Mar;10(3):129-34.PMID: 11886934 [PubMed - indexed for MEDLINE]Related articles

    21.

    Potential pharmacokinetics interference between alpha-glucosidase inhibitors and other oral antidiabetic agents.

    Scheen AJ, Lefèbvre PJ.

    Diabetes Care. 2002 Jan;25(1):247-8. No abstract available. PMID: 11772929 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Changes in blood glucose and plasma insulin levels induced by bradykinin in anaesthetized rats.

    Damas J, Hallet C, Lefebvre PJ.

    Br J Pharmacol. 2001 Nov;134(6):1312-8.PMID: 11704652 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Obesity: causes and new treatments.

    Lefèbvre PJ, Scheen AJ.

    Exp Clin Endocrinol Diabetes. 2001;109 Suppl 2:S215-24. Review.PMID: 11460572 [PubMed - indexed for MEDLINE]Related articles

    24.

    Risk of developing retinopathy in Diabetes Control and Complications Trial type 1 diabetic patients with good or poor metabolic control.

    Zhang L, Krzentowski G, Albert A, Lefebvre PJ.

    Diabetes Care. 2001 Jul;24(7):1275-9.PMID: 11423515 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Thymic expression of insulin-related genes in an animal model of autoimmune type 1 diabetes.

    Kecha-Kamoun O, Achour I, Martens H, Collette J, Lefebvre PJ, Greiner DL, Geenen V.

    Diabetes Metab Res Rev. 2001 Mar-Apr;17(2):146-52.PMID: 11307180 [PubMed - indexed for MEDLINE]Related articles

    26.

    Assessment of postprandial hepatic glycogen synthesis from uridine diphosphoglucose kinetics in obese and lean non-diabetic subjects.

    Paquot N, Schneiter P, Scheen AJ, Lefèbvre PJ, Tappy L.

    Int J Obes Relat Metab Disord. 2000 Oct;24(10):1297-302.PMID: 11093291 [PubMed - indexed for MEDLINE]Related articles

    27.

    [Guidelines for the treatment of arterial hypertension in diabetic patients]

    Scheen AJ, Rorive M, Estrella F, Weekers L, Lefèbvre PJ.

    Rev Med Liege. 2000 May;55(5):376-82. French. PMID: 10941301 [PubMed - indexed for MEDLINE]Related articles

    28.

    [GLycemic control in the diabetic patient. Recommendations after the DCCT and UKPDI studies]

    Paquot N, Scheen AJ, Lefèbvre PJ.

    Rev Med Liege. 2000 May;55(5):372-5. French. PMID: 10941300 [PubMed - indexed for MEDLINE]Related articles

    29.

    [Development and use of a telemedicine system for medical surveillance of diabetic patients]

    Ordoñez AJ, Rodriguez-Castro C, Zamora J, Rubio JL, Scheen AJ, Lefèbvre PJ, Castillo M.

    Journ Annu Diabetol Hotel Dieu. 2000:179-94. Review. French. No abstract available. PMID: 10932880 [PubMed - indexed for MEDLINE]Related articles

    30.

    Non-alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss.

    Luyckx FH, Lefebvre PJ, Scheen AJ.

    Diabetes Metab. 2000 Apr;26(2):98-106. Review.PMID: 10804323 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Antiobesity pharmacotherapy in the management of type 2 diabetes.

    Scheen AJ, Lefèbvre PJ.

    Diabetes Metab Res Rev. 2000 Mar-Apr;16(2):114-24. Review.PMID: 10751751 [PubMed - indexed for MEDLINE]Related articles

    32.

    [Thiazolidinediones]

    Scheen AJ, Paquot N, Letiexhe MR, Lefèbvre PJ.

    Journ Annu Diabetol Hotel Dieu. 1999:213-29. Review. French. No abstract available. PMID: 10732419 [PubMed - indexed for MEDLINE]Related articles

    33.
    34.

    State of current therapy and patient care in Europe.

    Lefebvre PJ, Scheen AJ.

    Int J Clin Pract Suppl. 1999 Sep;107:6-10. Review. No abstract available. PMID: 10692725 [PubMed - indexed for MEDLINE]Related articles

    35.

    Parallel reversibility of biological markers of the metabolic syndrome and liver steatosis after gastroplasty-induced weight loss in severe obesity.

    Luyckx FH, Scheen AJ, Desaive C, Thiry A, Lefébvre PJ.

    J Clin Endocrinol Metab. 1999 Nov;84(11):4293. No abstract available. PMID: 10566691 [PubMed - indexed for MEDLINE]Related articles

    36.

    Non-alcoholic steatohepatitis.

    Luyckx FH, Scheen AJ, Lefèbvre PJ.

    Lancet. 1999 Oct 9;354(9186):1298-9. No abstract available. PMID: 10520658 [PubMed - indexed for MEDLINE]Related articles

    37.

    Troglitazone: antihyperglycemic activity and potential role in the treatment of type 2 diabetes.

    Scheen AJ, Lefèbvre PJ.

    Diabetes Care. 1999 Sep;22(9):1568-77. Review.PMID: 10480527 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    [Glucotoxicity and lipotoxicity, two implicated accomplices in the vicious circle of type 2 diabetes]

    Scheen AJ, Paquot N, Lefèbvre PJ.

    Rev Med Liege. 1999 Jun;54(6):535-8. Review. French. PMID: 10446523 [PubMed - indexed for MEDLINE]Related articles

    40.

    Severe/extreme obesity: a medical disease requiring a surgical treatment?

    Scheen AJ, Luyckx FH, Desaive C, Lefèbvre PJ.

    Acta Clin Belg. 1999 Jun;54(3):154-61. Review.PMID: 10443044 [PubMed - indexed for MEDLINE]Related articles

    41.

    [Gestational diabetes: physiopathology and prognostic significance for the mother]

    Geronooz I, Scheen AJ, Lefèbvre PJ.

    Rev Med Liege. 1999 May;54(5):434-9. French. PMID: 10394243 [PubMed - indexed for MEDLINE]Related articles

    42.

    [Obesity and women: esthetic preoccupation or medical problem?]

    Luyckx FH, Scheen AJ, Lefèbvre PJ.

    Rev Med Liege. 1999 Apr;54(4):262-7. French. PMID: 10389468 [PubMed - indexed for MEDLINE]Related articles

    43.

    Glucose metabolism and the postprandial state.

    Lefèbvre PJ, Scheen AJ.

    Eur J Clin Invest. 1999 Jun;29 Suppl 2:1-6. Review.PMID: 10383603 [PubMed - indexed for MEDLINE]Related articles

    44.

    Insulin sensitivity, clearance and release in kininogen-deficient rats.

    Damas J, Bourdon V, Lefebvre PJ.

    Exp Physiol. 1999 May;84(3):549-57.PMID: 10362853 [PubMed - indexed for MEDLINE]Related articlesFree article

    45.

    [How I treat ... an individual with severe obesity and metabolic abnormalities with gastroplasty]

    Luyckx FH, Scheen AJ, Letiexhe MR, Desaive C, Gielen J, Lefèbvre PJ.

    Rev Med Liege. 1999 Mar;54(3):138-42. French. PMID: 10321101 [PubMed - indexed for MEDLINE]Related articles

    46.

    Pharmacological treatment of obesity: present status.

    Scheen AJ, Lefébvre PJ.

    Int J Obes Relat Metab Disord. 1999 Feb;23 Suppl 1:47-53. Review.PMID: 10193862 [PubMed - indexed for MEDLINE]Related articles

    47.

    [Pharma clinics. How I treat...a diabetic patient with severe obesity]

    Scheen AJ, Triches K, Luyckx F, Letiexhe MR, Lefèbvre PJ.

    Rev Med Liege. 1998 Jul;53(7):386-9. Review. French. PMID: 9926019 [PubMed - indexed for MEDLINE]Related articles

    48.

    Influence of the A-->G (-3826) uncoupling protein-1 gene (UCP1) variant on the dynamics of body weight before and after gastroplasty in morbidly obese subjects.

    Luyckx FH, Scheen AJ, Proenza AM, Strosberg AD, Lefèbvre PJ, Gielen JE.

    Int J Obes Relat Metab Disord. 1998 Dec;22(12):1244-5. No abstract available. PMID: 9877262 [PubMed - indexed for MEDLINE]Related articles

    49.

    The postprandial state and risk of cardiovascular disease.

    Lefèbvre PJ, Scheen AJ.

    Diabet Med. 1998;15 Suppl 4:S63-8. Review.PMID: 9868996 [PubMed - indexed for MEDLINE]Related articles

    50.

    [Viral implications in the etiopathogenesis of type 1 diabetes: current update]

    Radermecker R, Scheen AJ, Letiexhe MR, Lefèbvre PJ, De Mol P.

    Rev Med Liege. 1998 Oct;53(10):597-602. Review. French. PMID: 9857754 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...